ACP receives grant on safety when prescribing opioids
ACP and its curriculum partner, Pri-Med, have been awarded an educational grant from a company to develop and implement a training program that educates clinicians about safety and efficacy when prescribing opioids.
ACP and its curriculum partner, Pri-Med, have been awarded an educational grant by the REMS Program Companies, a group of manufacturers of extended-release and long-acting (ER/LA) opioids, to develop and implement a training program that educates clinicians about safety and efficacy when prescribing opioids.
The grant will incorporate elements of the FDA's recently approved guideline program, “Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics,” and will mark the first time that an FDA-required REMS program has included a continuing medical education (CME) component. The educational program will deliver critical training for primary care clinicians who prescribe ER/LA opioids in an effort to safely and effectively manage patients with chronic pain.
The initiative will be launched on June 15, 2013, through a certified, online curriculum that will be available online through ACP and Pri-Med.